New York University School of Law

CNA Appoints Steve Goldman to Senior Vice President, Financial Lines and Healthcare

Retrieved on: 
Monday, December 5, 2022
AIG, Wharton School of the University of Pennsylvania, New York University School of Law, Bachelor, ACE, CNA, University, Health care, Senior, University School, Insurance, Chubb, Management, Economics

CHICAGO, Dec. 5, 2022 /PRNewswire/ -- CNA today announced the appointment of Steve Goldman to Senior Vice President, Financial Lines and Healthcare.

Key Points: 
  • CHICAGO, Dec. 5, 2022 /PRNewswire/ -- CNA today announced the appointment of Steve Goldman to Senior Vice President, Financial Lines and Healthcare.
  • In this role, Steve will guide the strategic and operational plans across these product lines.
  • "Steve's proven track record of performance across all facets of the financial lines portfolio, and his deep leadership experience within the insurance industry, make him the ideal candidate to lead our Management Liability, Financial Institutions and Healthcare businesses," said Doug Worman, Executive Vice President and Global Head of Underwriting.
  • Steve brings to CNA more than 20 years of insurance experience, serving in various leadership positions at AIG, ACE and Chubb.

AffiniPay Expands Executive Team with Catherine Dawson as General Counsel

Retrieved on: 
Tuesday, November 15, 2022
Professional Services, Technology, Legal, Software, Finance, Fintech, Accounting, Spiceworks, Accounting, Engineering, Privacy, Multimedia, Financial technology, General counsel, Oberlin College, Disability, The Last Best Place, Practice management, University School, Software as a service, Education, Bachelor of Economics, New York University School of Law, Equine-assisted therapy, Wilson Sonsini Goodrich & Rosati, Management, Economics

AffiniPay , a leading SaaS for professionals, announced last week that Catherine Dawson will join the companys executive team and serve as General Counsel.

Key Points: 
  • AffiniPay , a leading SaaS for professionals, announced last week that Catherine Dawson will join the companys executive team and serve as General Counsel.
  • Catherine Dawson brings over 20 years of experience as an attorney, focusing on data privacy, cybersecurity, and mergers and acquisitions.
  • View the full release here: https://www.businesswire.com/news/home/20221115005704/en/
    AffiniPay Expands Executive Team with Catherine Dawson as General Counsel (Photo: Business Wire)
    We are excited to have Catherine Dawson join our AffiniPay executive team, said Dru Armstrong, Chief Executive Officer at AffiniPay.
  • For more information about Catherine Dawson and the rest of AffiniPays executive team, visit affinipay.com.

Securities and Exchange Commission Ramps Up Enforcement Against Public Companies and Subsidiaries in FY 2022

Retrieved on: 
Wednesday, November 16, 2022
SEC, Cornerstone Research, Law, Guilt, NEW, Research, New York University Stern School of Business, Name, Business, School, U.S. Securities and Exchange Commission, Disclosure, Curriculum, Education, Cornerstone, University School, New York University School of Law, Faculty, Broker-dealer, Security (finance), Pharmaceutical industry, SEED

NEW YORK, Nov. 16, 2022 /PRNewswire-PRWeb/ -- The U.S. Securities and Exchange Commission filed 68 enforcement actions against public companies and subsidiaries in the first full fiscal year of Chair Gary Gensler's tenure. Monetary settlements imposed in public company or subsidiary actions reached $2.8 billion, according to a report released today by the NYU Pollack Center for Law & Business and Cornerstone Research.

Key Points: 
  • NEW YORK, Nov. 16, 2022 /PRNewswire-PRWeb/ -- The U.S. Securities and Exchange Commission filed 68 enforcement actions against public companies and subsidiaries in the first full fiscal year of Chair Gary Gensler's tenure.
  • The report, SEC Enforcement Activity: Public Companies and SubsidiariesFiscal Year 2022 Update , analyzes information from the Securities Enforcement Empirical Database .
  • The 68 enforcement actions in FY 2022, which ended Sept. 30, reflected a 28% increase from the previous fiscal year.
  • The SEC imposed monetary settlements on 97% of the 75 public company and subsidiary defendants that settled in FY 2022.

Sotera Health Announces Alex Dimitrief as General Counsel

Retrieved on: 
Wednesday, November 2, 2022
SHC, Kirkland & Ellis, Oxide, CEO, General officer, Ronald McDonald House Charities, Leadership, House, Organization, GLOBE, Partner, Nasdaq, White House Fellows, Harvard Law School, Executive, White House, GE, General counsel, Update, Ethylene oxide, Company, Investor relations, New York University School of Law, Kirkland, Senior, Solution, Science, Tulane University Law School, General Electric, Management

Mr. Dimitrief previously served in a variety of senior leadership roles at General Electric (GE), including as President and CEO of General Electrics Global Growth Organization and as General Counsel of GE.

Key Points: 
  • Mr. Dimitrief previously served in a variety of senior leadership roles at General Electric (GE), including as President and CEO of General Electrics Global Growth Organization and as General Counsel of GE.
  • He comes to Sotera Health from Zeughauser Group, where Mr. Dimitrief has been advising legal departments and law firms on a broad variety of strategic issues.
  • I am excited to join Michael and the leadership team at Sotera Health, said Alex Dimitrief.
  • Matthew J. Klaben, who had been serving as interim General Counsel, will return to his role as Deputy General Counsel and remains co-chair of the Companys ESG Committee.

Amneal Expands Leadership Team with Appointment of Senior Leaders in Quality and Regulatory

Retrieved on: 
Monday, October 31, 2022
Biotechnology, Pharmaceutical, Health, Medical Supplies, Growth, Willkie Farr & Gallagher, District court, Quality control, University, Research, Industry, COVID-19, Federation, Human, VP, Investment, Private Securities Litigation Reform Act, Food, Company, Associate, FDA, Moses Austin, Medication, Division, NYSE, District, Ownership, U.S. Securities and Exchange Commission, Senior, Central nervous system, Security (finance), Actavis, Acquisition, Generic, Common stock, New York University School of Law, Risk, Degenerative disease, International relations, Pennsylvania Office of General Counsel, LLP, Annual report, University School, Intellectual property, Generic drug, Legislation, CDER, OGD, Weather, Forward-looking statement, Management, Risk management, Amneal Pharmaceuticals, Chemistry, Science, Policy, Mylan

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) today announced it has appointed Reem Malki as Senior Vice President, Chief Quality Officer, and Maryll W. Toufanian as Senior Vice President, Regulatory Strategy and Policy.

Key Points: 
  • Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal or the Company) today announced it has appointed Reem Malki as Senior Vice President, Chief Quality Officer, and Maryll W. Toufanian as Senior Vice President, Regulatory Strategy and Policy.
  • Prior to joining Alvotech, Ms. Malki held various senior leadership roles at Mylan, including Head of Global Quality Operations.
  • Amneal Co-Chief Executive Officers Chirag Patel and Chintu Patel said, We are so excited to welcome Reem and Maryll to our leadership team.
  • As the company expands into new growth areas, we will strive to maintain that industry leading quality reputation, said Reem Malki, Senior Vice President, Chief Quality Officer.

Blackwells Capital Nominates Two Highly Qualified Directors for Election to the Necessity Retail REIT Inc. Board of Directors at the 2023 Annual Meeting

Retrieved on: 
Tuesday, October 25, 2022
NYSE, Policy, Board, Acquisition, Goldman Sachs, Creation, GLOBE, Income Tax Department, Sale, The Related Companies, NEW, Annual general meeting, Adoption, Insurance, Partner, University School, Technology, Interest, Investment, Real estate investment trust, Company, RTL, Corporate governance, Management, NAV, CEO, Baylor University, GNL, Webster Bank, New York University School of Law, REIT, Blackwells, We Have the Facts and We're Voting Yes, Audit, Public relations, Pharmaceutical industry, Real estate

NEW YORK, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Blackwells Capital LLC (together with its affiliates “Blackwells”), an owner of 100 shares of common stock and equivalents of the Necessity Retail REIT Inc. (NYSE: RTL) (“Necessity Retail REIT,” “RTL” or the “Company”), today announced it has nominated two exceptional candidates for election to RTL’s Board of Directors at the upcoming 2023 Annual Meeting of Shareholders (the “2023 Annual Meeting”) and plans to pursue a number of corporate governance initiatives.

Key Points: 
  • Blackwells nominees for election to the RTL Board of Directors at the 2023 Annual Meeting are:
    Richard L. OToole.
  • Prior to Paul Hastings LLP, Mr. OToole was a Partner in the Tax Department at Battle Fowler LLP for 13 years.
  • Mr. OToole is a member of the board of directors of Webster Financial Corporation and Equinox Holdings, Inc.
    Jim Lozier.
  • Robert), a global real estate investment management company, and was responsible for managing the joint venture between Goldman Sachs and J.E.

Blackwells Capital Nominates Two Highly Qualified Directors for Election to the Global Net Lease Inc. Board of Directors at the 2023 Annual Meeting

Retrieved on: 
Tuesday, October 25, 2022
Board, Insurance, Income Tax Department, Adoption, Investment, Company, Baylor University, AR, Policy, GLOBE, Sale, Partner, The Related Companies, University School, Goldman Sachs, Technology, Real estate investment trust, RTL, Management, CEO, Webster Bank, MassINC, Blackwells, LLC, Acquisition, Net asset value, Annual general meeting, Goldman, GNL, REIT, Review, NYSE, Creation, NEW, Behavior, Trustee, Letter, Equity, Corporate governance, New York University School of Law, Audit, Holding company, Music, Security (finance), Real estate

NEW YORK, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Blackwells Capital LLC (together with its affiliates “Blackwells”), today announced it has nominated two exceptional candidates for election to the board of directors of Global Net Lease Inc. (NYSE: GNL) (“Global Net Lease,” “GNL” or the “Company”) at the upcoming 2023 Annual Meeting of Shareholders (the “2023 Annual Meeting”) and plans to pursue a number of corporate governance initiatives. Blackwells, together with its affiliates, is one of the largest owners of common stock and equivalents of GNL.

Key Points: 
  • Blackwells, together with its affiliates, is one of the largest owners of common stock and equivalents of GNL.
  • We believe the board of directors and management have been, for years, complicit in corporate piracy and are solely to blame.
  • In September, Blackwells communicated its frustrations to the Board in a letter, attached hereto.
  • Blackwells nominees for election to the GNL Board of Directors at the 2023 Annual Meeting are:
    Richard L. OToole.

Advanced Private Equity Term Sheets and Series A Documents: State-Of-The-Art Analysis, Forms and Commentary to Guide You Through the Venture Finance Sector - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 20, 2022
Professional Services, Finance, U.S. Department of Defense Strategy for Operating in Cyberspace, Cornell University, Herbert Fisk Johnson III, LBO, Financial institution, McCarter & English, U.S. Department of Commerce Office of Security, Ropes & Gray, Commerce, Boston Bar Association, JD, Capitol Hill, Anatomy, Risk assessment, European Commission Investment Plan for Europe, Chapter One, General partnership, NYU, General counsel, Chapter Eight, Venture capital, Business, Security (finance), Investment, REIT, Cram, LP, Technology, Checklist, Louisiana State University, LLM, Methodist University, New York University School of Law, International business strategy, Southern Methodist University, Rope, ISBN, McCarter, Financial services, Tax

The "Advanced Private Equity Term Sheets and Series A Documents" book has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Advanced Private Equity Term Sheets and Series A Documents" book has been added to ResearchAndMarkets.com's offering.
  • This encyclopedic guide is packed with state-of-the-art analysis, forms and commentary, all designed to help you master the most crucial stages of the venture financing process.
  • TheAdvanced Private Equity Term Sheets and Series A Documents book examines all of the deal terms you may encounter - anti-dilution protection, warrant coverage, liquidation preferences, and others.
  • A recognized pioneer of the national private equity and venture capital bar, Mr. Bartlett contributed to the original models for private equity and fund of fund partnerships.

Skin Expert Dr. Cameron Rokhsar Joins Exclusive Haute Beauty Network

Retrieved on: 
Thursday, October 20, 2022
Physician, Chin, Medicine, Self-signed certificate, U.S. News & World Report, Lenox Hill Hospital, ABC News, Mohs surgery, CBS News, Research, Nose, Private practice, Albert Einstein College of Medicine, Haute Living, Today, Eyelid, Mount Sinai Hospital, Education, Fox News, Castle, Harvard University, Television, Associate, News, Beauty, New York University School of Law, NBC News, Acne, Skin cancer, Good Morning America, Fashion, Veterinary medicine, Dermatology, New York (magazine), Fraxel

MANHATTAN, N.Y., Oct. 20, 2022 /PRNewswire-PRWeb/ -- Dr. Cameron K. Rokhsar, M.D., F.A.A.D., F.A.A.C.S., an internationally renowned laser surgeon, is a double Board Certified dermatologist, dermatologic mohs surgeon, and fellowship-trained cosmetic and laser surgeon in private practice in Manhattan and Long Island. He practices cosmetic and general dermatology with a particular focus on laser and other nonsurgical treatments, aesthetic enhancements with fillers, skin cancer, and its treatment through Mohs Micrographic Surgery, minimally invasive liposuction, and the treatment of acne and acne scars. Dr. Rokhsar is an Associate Professor of Dermatology at Mount Sinai Hospital, where he teaches the cosmetic dermatology clinic.

Key Points: 
  • Dr. Cameron Rokhsar joins Haute Beauty Network as a skin expert representing the Manhattan, NY market.
  • Dr. Rokhsar is an Associate Professor of Dermatology at Mount Sinai Hospital, where he teaches the cosmetic dermatology clinic.
  • As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.
  • For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/
    Brooke Klaiman, Haute Beauty by Haute Living, 5612122126, [email protected]

Royalty Pharma Announces Expansion of Leadership Team

Retrieved on: 
Wednesday, October 12, 2022
U.S. Securities and Exchange Commission, Sale, JD, Royalty Pharma, EVP, AbbVie, Goodwin Procter, Investment, General counsel, Tufts University, Publication, Research, Art, Equity Group Holdings, Nasdaq, Private Securities Litigation Reform Act, NEW, New York University School of Law, Tulane University Law School, Ecosystem, GLOBE, McGivern, Boston University, Forward-looking statement, EDGAR, Princeton University, Terminology, AB, Fine chemical, Management, Music, Ivacaftor

Art McGivern joins Royalty Pharma as EVP, Investments & General Counsel

Key Points: 
  • Art McGivern joins Royalty Pharma as EVP, Investments & General Counsel
    George Lloyd promoted to EVP, Investments & Chief Legal Officer
    NEW YORK, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced an expansion of its leadership team.
  • Pablo Legorreta, Royalty Pharmas founder and Chief Executive Officer, commented, We are thrilled that Art will join Royalty Pharma and strengthen our leadership team.
  • As Royalty Pharma has grown, so too have the demands on the legal team and Art's addition will expand our capacity to execute on our transaction pipeline.
  • He joined Royalty Pharma in 2011 after representing Royalty Pharma on all transactional work since 2006.